Ryan Specialty Group Holdings, Inc. (RYAN) experienced a significant pre-market plunge of 6.53% on Friday, reflecting negative investor sentiment following a series of analyst downgrades.

The sharp decline comes as multiple financial institutions revised their price targets for the insurance brokerage firm downward. Barclays lowered its target to $39 from $41 while maintaining an Overweight rating. Mizuho and Piper Sandler both cut their targets to $35 from $42 and $43 respectively, while KBW reduced its target to $42 from $49.

These coordinated price target reductions from several major analysts suggest a reassessment of the company's valuation prospects, prompting the substantial pre-market sell-off.